Když se řekne české pivo, většina lidí si představí půllitr se zlatavým mokem a bohatou pěnou. Poslední roky však přinesly do pivního světa tichou revoluci. Pivo bez alkoholu. A přestože kdysi bývalo na okraji zájmu, dnes se z „nealka“ stává plnohodnotná součást české pivní scény a český konzument, důvěrně spjatý s pivní kulturou, si začíná všímat rozdílů mezi značkami a styly.Ještě před několika lety jsme nealkoholické pivo drželi v ruce jen tehdy, když jsme před sebou měli cestu autem. Dnes už po něm ale saháme z jiných důvodů – pro jeho chuť, pro zdraví, kvůli sportu nebo prostě ze zvědavosti, kam až se může české pivovarnictví bez jediné kapky alkoholu posunout.<h4>Zrod nealkoholického piva</h4>První nealkoholické pivo na českém území vzniklo již v sedmdesátých letech 20. století. Důvodem pro jeho výrobu ovšem nebyl strach z dopadů alkoholu na lidské zdraví nebo úsilí o zvýšení pozitivních vlastností piva, nýbrž jen potřeba podpořit bezpečnost na silnicích. Název Pito pro tento produkt vznikl spojením slov „pivo“ a „auto“. Mezi lidmi koluje mýtus, že nealkoholické pivo je jen limonáda s pivní příchutí. Pravda však je, že je to stále plnohodnotné pivo, které se vaří ze sladu, z chmele, vody a kvasnic.Trik spočívá v řešení, jak omezit, nebo zcela odstranit alkohol, aniž zmizí autentická chuť piva. Nejjednodušší metodou výroby nealkoholického piva je uvařit nízkostupňovou mladinu, jež má na startu kvašení nízký obsah zkvasitelných cukrů, což je například takzvaná „sklářská osmička“. Pivo se proto nechá klasicky kvasit, ale v předem definované fázi se tento proces zastaví, aby nenarůstal obsah alkoholu. Kvašení lze ukončit zchlazením mladiny, nebo naopak jejím zahřátím, případně filtrací a podobně.<h4>Moderní technologie a chuť</h4>Ačkoliv zpočátku klasický český pivař nadále preferoval alkoholickou verzi národního nápoje, poptávka po chuťově kvalitní nealkoholické verzi od sedmdesátých let narůstala. V devadesátých letech se díky rozvíjející se pivovarské technologii již dařilo vařit piva s příjemným chuťovým profilem. Cílem bylo uvařit klasické pivo a alkohol z něj následně odstranit. K tomuto účelu se využívaly, a stále se využívají, postupy jako vakuová destilace, reverzní osmóza, dialýza a podobně.Jedním z úskalí, která u tohoto procesu mohou nastat, je zahuštění piva, proto je nezbytné produkt na konci procesu zpětně naředit vodou. To je také důvodem, proč mnoho pivařů namítá, že taková piva jsou „nudná“, „plochá“ či „nevýrazná“. Možnost vrátit pivům osobitost nabízejí jiné rody kvasinek, například Saccharomycodes ludwigii, které nezkvašují maltózu, což je hlavní cukr obsažený v pivovarské mladině. Zároveň do piva vnáší další chuťové a vonné látky jako estery a vyšší alkoholy, jež pomáhají maskovat „mladinovou“ chuť typickou pro některá jiná nealkoholická piva.Česko, země, kde pivo patří k národní identitě stejně jako hokej nebo hrady, se k nealkoholické revoluci pivních náhražkách nebo ovocných nealkoholických variantách, nýbrž po autentickém pivu, které má říz a charakter. I dnes někteří namítají, že nealkoholické pivo není pivo, případně že je to pošlapávání tradic a české pivní kultury.<h4>Nová kapitola pivovarnictví</h4>Sládci proto začali experimentovat s různými styly od ležáků po IPA, dokonce i s pšeničnými pivy bez promile. Výsledek? Sortiment nealkoholických piv se rozrostl, jejich kvalita se prudce zvýšila a chuť se stala i jejich silnou stránkou. Pokud se tedy rozvine produkce nealkoholických piv, rozhodně nepřijdeme o naše české „tekuté zlato“. Spíše společnosti umožníme získat nápoj bez škodlivého alkoholu při zachování pozitivních účinků na lidský organismus. Vždyť nealkoholické pivo dnes otevírají sportovci po tréninku, cyklisté na výletech i ti, kdo chtějí prostě zůstat ve formě. V zemi, kde se pivo prolíná s každodenním životem, je to vlastně přirozený vývoj – respekt k tradici, ale i schopnost změnit návyky v souladu s dobou. Češi dokazují, že i pivo bez promile může mít duši, a že „nealko“ není náhradou, ale dalším projevem naší pivní hrdosti.Lukáš Kučera pro National Geographic.

Lukáš Kučera pro National Geographic: Tradice versus nová vlna

🎤 Přednášející: Simona Wawroszová<h3>VIZE 2025: Stanovení nitrosaminů v uzeninách pomocí LC-MS/MS: citlivý a robustní přístup</h3>Nitrosaminy patří mezi významné kontaminanty v masných výrobcích, zejména v uzeninách, kde vznikají reakcí dusitanů nebo dusičnanů s aminy za kyselých podmínek či při tepelném zpracování a uzení. Jejich analytické stanovení představuje výzvu kvůli nízkým koncentracím a komplexní matrici vzorků. Moderní LC-MS/MS přístupy však umožňují jejich citlivou a selektivní detekci.<h4>Nitrosaminy v masných výrobcích: vznik a význam</h4>Nitrosaminy vznikají při reakci dusitanů nebo dusičnanů s aminy, typicky při technologickém zpracování masa. Mezi hlavní zdroje patří fermentované a sušené salámy, slanina nebo uzené produkty. Nejčastěji sledované sloučeniny zahrnují NDMA, NDEA, NPIP, NPYR, NMOR a NDBA.Zdravotní význam nitrosaminů souvisí s jejich schopností tvořit v organismu reaktivní intermediáty poškozující DNA, což může vést k mutacím a zvýšenému riziku nádorových onemocnění. IARC klasifikovala zpracované masné výrobky jako prokazatelně karcinogenní mimo jiné právě kvůli jejich obsahu.<h4>Legislativní rámec</h4>Regulace nitrosaminů se liší podle regionu. V EU není stanoven přímý limit pro jejich obsah v masných výrobcích, ale regulován je přídavek dusitanů. Naproti tomu například USA stanovují limit pro sumu těkavých nitrosaminů ve slanině (10 µg/kg). Podobné limity existují i v Kanadě nebo Číně.<h4><a target="_blank" rel="noopener noreferrer" href="https://lcms.cz/products/554">LC-MS/MS</a> přístup k analýze nitrosaminů</h4>Nitrosaminy se v potravinách vyskytují ve velmi nízkých koncentracích, proto je nutná vysoce citlivá hmotnostní spektrometrie. Metodika využívá tandemovou MS detekci v režimu MRM, která zajišťuje selektivní kvantifikaci i konfirmaci analytů.<h4>Příprava vzorku</h4>Pro extrakci nitrosaminů z masné matrice je použita metoda QuEChERS, která nabízí rychlou a jednoduchou přípravu vzorků. Postup zahrnuje homogenizaci vzorku, extrakci acetonitrilem s kyselinou mravenčí, přídavek solí, centrifugaci a následné čištění pomocí dSPE.<h4>Chromatografické a MS podmínky</h4>Separace probíhá na koloně ACQUITY UPLC CSH Phenyl-Hexyl při teplotě 40 °C a průtoku 0,6 mL/min. Mobilní fáze tvoří voda a methanol s přídavkem kyseliny mravenčí.MS detekce využívá ionizační zdroj APCI v pozitivním módu. Optimalizace parametrů, jako jsou kolizní energie nebo napětí kužele, je realizována v <a target="_blank" rel="noopener noreferrer" href="https://lcms.cz/products/1544">softwaru waters_connect</a> pomocí nástrojů pro MRM optimalizaci.<h4>Analytické parametry a validační výsledky</h4>Metoda dosahuje velmi nízkých limitů kvantifikace v rozpouštědle i matrici. Lineární kalibrace byla potvrzena až do 50 ng/mL s korelačními koeficienty přibližně 0,999.V testovaných vzorcích fermentovaných salámů byly dosaženy výtěžnosti v rozmezí 89–101 % a extrapolované LOQ až 0,08 µg/kg. Tyto výsledky potvrzují vhodnost metody pro rutinní potravinářské analýzy.<h4>Závěr</h4>Stanovení nitrosaminů v masných výrobcích vyžaduje kombinaci citlivé detekce, selektivní analýzy a efektivní přípravy vzorků. Prezentovaná LC-MS/MS metodika s využitím QuEChERS extrakce a optimalizovaného MRM režimu poskytuje robustní řešení pro monitoring těchto kontaminantů v potravinách.

Waters VIZE 2025: Stanovení nitrosaminů v uzeninách

Navštivte stánek LabRulez na veletrhu <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/events/871">analytica 2026</a> v Mnichově, který startuje již zítra! Najdete nás v hale A1, stánek A1.506. Na místě budete moci vidět živé ukázky toho, jak portály LabRulez fungují a také vybrané analytické přístroje z naší bazarové sekce.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Lab_Rulez_at_Analytica_2026_Floor_plan_55e1057e03.jpg" alt="LabRulez na veletrhu analytica 2026: Plán Haly A1 a umístění stánku" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Lab_Rulez_at_Analytica_2026_Floor_plan_55e1057e03.jpg 245w," sizes="100vw" width="1516" height="881"><h4>Chcete vědět, jak portály LabRulez fungují?</h4>➡︎<a target="_blank" rel="noopener noreferrer" href="https://lcms.cz/">LabRulezLCMS</a>➡︎<a target="_blank" rel="noopener noreferrer" href="https://gcms.cz/">LabRulezGCMS</a>➡︎<a target="_blank" rel="noopener noreferrer" href="https://icpms.cz/">LabRulezICPMS</a><ul><li>jedinečné on-line řešení pro váš marketing</li><li>spektrum cílených návštěvníků z oblasti analytické chemie</li><li>nejmodernější technologie a unikátní koncept</li><li>design navržený pro většinu chytrých zařízení - PC, mobily nebo tablety</li><li>pokročilé statistické funkce, které jsou plně k dispozici uživatelům</li></ul><h4>Nabízené služby</h4><h5>Novinky + zprávy vaší společnosti</h5><ul><li>publikace novinek týkající se vaší instrumentace, aplikací, služeb, informací o pořádaných akcích, volných pracovních pozicích atd.</li><li>novinky jsou publikovány jak na portálech, tak na našich sociálních sítích</li></ul><h5>Knihovna - všechny dokumenty na jednom místě</h5><ul><li>aplikace, postery, prezentace, technické články, brožury, specifikace - to vše najdete v naší unikátní knihovně</li><li>rychlé a pokročilé vyhledávání</li><li>aktuálně je v naší databázi přes 32 000 dokumentů</li></ul><h5>Webináře</h5><ul><li>budoucí i již proběhlé webináře z oblasti analytické chemie</li><li>v databázi je aktuálně více než 5 500 webinářů z oblasti chromatografie, hmotnostní spektrometrie a spektroskopie</li></ul><h5>Kariéra</h5><ul><li>cílená nabídka pracovních pozic v oboru analytické chemie</li><li>přehledné filtrování pozic dle zaměření nebo místa výkonu práce</li><li>zvýšená viditelnost inzerátu</li></ul><h5>Společnosti</h5><ul><li>profil společnosti obsahující důležité informace a kontakty</li><li>propojení veškerých Vašich aktivit na našem portálu jako jsou Novinky, dokumenty v Knihovně, Webináře, Nebližší akce, Kariéra nebo např. Píše se o nás v Novinkách Vašich partnerů nebo zákazníků</li><li>propojení také s Vašimi Produkty na portálech LabRulez</li></ul><h5>Produkty a služby</h5><ul><li>rozsáhlý přehled instrumentálních technik a služeb</li><li>cílení na komunitu analytických chemiků a zákazníky z rostoucího on-line světa</li></ul><h5>Bazar</h5><h5>Nákup a prodej zánovní techniky</h5><ul><li>odkoupíme od Vás analytickou instrumentaci všech značek a stáří</li><li>prodejte svou techniku prostřednictvím LabRulez</li><li>poptejte a nakupte kompletní sestavy, moduly nebo náhradní díly s garancí a servisem</li></ul><h4>Co vše bude na našem stánku k vidění?</h4>Přijďte si prohlédnout vybrané náhradní díly a moduly z naší bazarové sekce. Jedná se jak o nové, tak i testované a bazarové položky.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Lab_Rulez_at_analytica_2026_bazar_7edf4a0872.jpg" alt="LabRulez stánek na veletrhu analytica 2026 - ukázka bazarového sortimentu" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Lab_Rulez_at_analytica_2026_bazar_7edf4a0872.jpg 88w," sizes="100vw" width="1600" height="2844"><h5><a target="_blank" rel="noopener noreferrer" href="https://lcms.cz/bazaar">LabRulezLCMS Bazar</a></h5><ul><li>Náhradní díly pro LC/MS: <a target="_blank" rel="noopener noreferrer" href="https://lcms.cz/bazaar?category=378">Turbo pumpy pro LC/MS</a></li><li>Náhradní díly pro HPLC:&nbsp;<ul><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.cz/bazaar?category=397">odplyňovače (degassery) pro HPLC/UHPLC</a></li><li>automatické ventily pro HPLC</li><li>HPLC komponenty pro řady Agilent 1100, 1200 a 1260 Infinity II</li></ul></li><li>Spotřební materiál:&nbsp;<ul><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.cz/bazaar?category=377">HPLC lampy</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.cz/bazaar?category=48">HPLC kolony</a></li></ul></li></ul><h5><a target="_blank" rel="noopener noreferrer" href="https://gcms.cz/bazaar">LabRulezGCMS Bazar</a></h5><ul><li>Náhradní díly pro GC/MS: <a target="_blank" rel="noopener noreferrer" href="https://gcms.cz/bazaar?category=367&amp;search=turbo">Turbo pumpy pro GC/MS</a></li><li>Náhradní díly pro GC: <a target="_blank" rel="noopener noreferrer" href="https://gcms.cz/bazaar?category=366&amp;search=EPC">EPC moduly</a></li><li>Dávkování vzorků: <a target="_blank" rel="noopener noreferrer" href="https://gcms.cz/bazaar/432">Autosampler 7693A pro GC</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://gcms.cz/bazaar?category=7">GC kolony</a> a další vybraný spotřební materiál</li></ul>

LabRulez na veletrhu analytica 2026

Potraviny

Přednáška

Video

Článek

Produkt

Nejbližší akce

Vše ze světa analytické chemie na jednom místě. Propojujeme lidi při řešení jejich problémů. U nás naleznete všechny potřebné informace snadno, rychle a přehledně. Přestaňte hledat a začněte nacházet.

LabRulez

Univerzita Palackého v Olomouci je vysoká škola s dlouhou tradicí. Byla založena již v 16. století a je tak nejstarší vysokou školou na Moravě a druhou nejstarší v České republice. V současnosti představuje moderní vzdělávací instituci se širokou nabídkou studijních oborů a bohatou vědeckou činností.

Univerzita Palackého v Olomouci

Firmu Waters založil v roce 1958 pan James Waters. Od té doby se společnost Waters specializuje na kapalinovou chromatografii a hmotnostní spektrometrii. Divize TA Instruments působí na poli termální analýzy. V České republice je Waters zastoupen přímou pobočkou, která sídlí v Praze.

Waters Gesellschaft

Technology Networks

Phenomenex

Thermo Fisher Scientific

Waters Corporation

<h3>Solving Problems That Matter - a Waters webinar series featuring USP speakers</h3><h4>Episode 8: Lipid nanoparticles</h4><div class="summary-section section">Developing safe, compliant and efficacious lipid nanoparticles (LNP) requires adequate testing of the individual lipid components and impurities. In this webinar Anni Chang from the USP Excipient team will share current and future excipient solution approaches and describe how the USP provides support for stakeholders in discovery and early-stage development. Then Duanduan Han will discuss the benefits of mass detection for critical impurities analysis, and Empower software workflows for compliant and straightforward method migration from development to QC labs. Duanduan will also highlight how multi-angle light scattering (MALS) detection can be used to characterize the LNP.<h5>Key learning objectives</h5><ul><li>Explore current and future USP solutions for lipid nanoparticles (LNP)</li><li>Learn how mass detection and Empower software-based workflows expedite and enhance routine testing of LNP components and impurities</li><li>Discover orthogonal insights enabled by multi-angle light scattering detection (MALS)</li></ul><h5>Who should attend</h5>Scientists involved with lipid nanoparticle analysis<blockquote>Presenter: Anni Chang, Ph.D. (Sr Scientist II, Excipients Unit, US Pharmacopeia)Dr. Anni Chang is currently a Senior Scientist II in the Excipients unit at the United States Pharmacopeia (USP). In her current role, she is responsible for developing, revising, and modernizing USP monographs. One of her focus areas is lipid excipients used in nanomaterial carriers.Dr. Chang has more than 15 years of experience in the biotech/pharmaceutical industry in analytical method development, validation, and transfer. She received her Ph.D. in Chemistry from University of Maryland, College Park, Maryland, USA. Dr. Chang is also active in the American Association of Pharmaceutical Scientists and serves as a Member Engagement Manager in the Lipid Based Drug Delivery community.Presenter: Duanduan Han, Ph.D. (Senior Scientist QA/QC Biologics Solutions group, Waters Corporation)Duanduan is a Senior Scientist in the QA/QC Biologics Solutions group at Waters Corporation headquarters in Milford, MA. She joined Waters in 2021, and she has focused on LC method development in composition analysis, impurity profiling, and raw material screening of lipid nanoparticle components and products. Additionally, she has explored other subjects of pharmaceutical analysis including surfactant, protein, and peptide. Prior to joining Waters, she received her PhD in chemical engineering from Texas A&amp;M University.Presenter: Panelist: Martin Kurnik, Ph.D. (Senior Scientist, Analytical Sciences, Waters | Wyatt Technology​)Martin Kurnik is a senior scientist in the Analytical Sciences team at Waters | Wyatt Technology. He helps customers identify and develop the best solutions for their analytical needs by leveraging his expertise in multi-angle light scattering and dynamic light scattering as well as a wide range of other leading techniques for biomolecular characterization. His postdoctoral research in protein folding and misfolding biophysics focused on understanding and preventing misfolding in bulk solution and on artificial surfaces used in medicine and biotechnology, and he has also developed protein- and aptamer-based electrochemical biosensors for continuous real-time measurements in vitro and in vivo. Martin received his M.Sc. in Chemistry and Ph.D. in Biochemistry from Stockholm University, Sweden.Moderated by: Isabelle Vu Trieu (Pharmaceutical Market Development Manager, Americas, Waters Corporation)Isabelle is a business development professional dedicated to delivering benefits to analytical scientists in the life sciences industry. With over 20 years of experience in providing chromatography and mass spectrometry solutions, Isabelle is particularly interested in helping pharmaceutical scientists achieve the data quality and integrity needed to drive decisions for drug quality, safety and efficacy. Isabelle joined Waters in 2009 and currently manages the development of the pharmaceutical market in the Americas. She holds Masters’ degrees in Chemistry from Columbia University and the University Claude Bernard in Lyon, France as well as a Chemical Engineering degree from Ecole Supérieure de Chimie Physique Electronique in Lyon, France.</blockquote></div>

Waters Corporation: Solving Problems That Matter - a Waters webinar series featuring USP speakers

Lipid nanoparticles

Solving Problems That Matter - a Waters webinar series featuring USP speakers. Episode 8: Complex excipients: Lipid nanoparticles.

Complex excipients: Lipid nanoparticles

Learn how Light Scattering can benefit your drug development!
The scientific community aims to enhance transparency and reliability in published research, with a specific focus on the quality of biological reagents, notably recombinant proteins. Concerns have been raised regarding irreproducible results, prompting discussions on common quality issues associated with recombinant proteins and their impact on downstream applications. In response, professionals in protein purification and characterization have collaboratively developed guidelines for improved quality control.
These guidelines include minimal information requirements for protein identity, production parameters, and long-term stability, as well as a minimal set of quality tests for purity, homogeneity, and identity. Additional recommendations cover DNA contamination, “spectral and thermal denaturation signatures”, homogeneity, “competent fraction”, storage conditions, batch-to-batch reproducibility, and other factors based on intended applications. 
Evaluation of these guidelines over a one-year period suggests that their implementation can enhance experimental reliability and optimize protein quality. Investing in protein QC benefits all stakeholders in life sciences, including researchers, editors, and funding agencies, by improving data accuracy and minimizing resource wastage
Key learning topics:
<ul>
<li>The latest guidelines for Quality control of Protein purification and characterisation 
</li>
<li>How these guidelines can enhance reliability and improve protein quality in your labs
</li>
<li>How to reduce wastage and improve data accuracy in protein quality control
</li>
</ul>
Who should attend?
<ul>
<li>Lab Managers and Scientists working in upstream recombinant protein production and QC
</li>
<li>Lab Managers and Scientists working in downstream protein purification QC
</li>
</ul>
<blockquote>
Presenter: Dr. André Matagne (Full Professor, University of Liège, Belgium)
</blockquote>
<blockquote>
Dr. Matange is a Full Professor at the University of Liège, Belgium, where he is the chair at the Centre for Protein Engineering within the Faculty of Sciences.
</blockquote>
<blockquote>
With a background in biochemistry, his research is primarily focused on proteins, particularly exploring their folding, stability, and biological activity. Notably, he has played a pivotal role in the development of Robotein®, an advanced technological platform designed for to high throughput protein expression, purification, formulation, and analysis.
</blockquote>
<blockquote>
Since 2016, Dr.Matagnehas been honored as an elected titular member of the Royal Academy of Sciences in Belgium.
</blockquote>

Waters Corporation: Quality Control of Purified Proteins to Improve Research Data Reproducibility: Improving the Time-Efficiency and Quality of Your Results​

Quality Control of Purified Proteins to Improve Research Data Reproducibility: Improving the Time-Efficiency and Quality of Your Results​

Learn how Light Scattering can benefit your drug development.

Quality Control of Purified Proteins to Improve Research

The sample throughput of high-sensitivity liquid chromatography-mass spectrometry (LC-MS) based proteomics analysis is restricted by the pressure limitations of LC and column hardware, with some methods wasting as much as 50% of the method cycle time outside of MS acquisition.
Traditional routes for boosting throughput include shorter columns and gradients, higher flow rates, and using trap-and-elute workflows – all of which introduce trade-offs in sensitivity and proteome depth.
The Thermo Scientific™ Vanquish™ Neo tandem direct injection workflow leverages hardware innovations and software intelligence to eliminate method overhead while maintaining data quality across nano, capillary, and micro-flow LC-MS.
In this webinar experts from Evotec and Bayer will showcase how they implemented the tandem direct injection workflow for their proteomics work. Dr. Nagarjuna Nagaraj will present on how Evotec is using tandem direct injection with nano-LC columns packed in-house to boost sample throughput of their chemoproteomics screening pipeline, while Dr. Alexander Boychenko from Bayer will discuss how his lab is using a micro-flow tandem direct injection approach to analyze plasma samples for translational proteomics.
Learning Objectives
<ul>
<li>See how minimizing LC-MS method overhead can accelerate sample throughput while maintaining proteome depth
</li>
<li>Discover how labs are using tandem direct injection for chemoproteomics and translational proteomics applications
</li>
<li>Learn how to implement tandem direct injection in your proteomics workflow
</li>
</ul>
<blockquote>
Presenter: Dr. Nagarjuna Nagaraj (Group Leader High Sensitivity Proteomics, Evotec)
</blockquote>
<blockquote>
Dr. Nagarjuna Nagaraj is a proteomics group leader at Evotec focusing on high sensitivity and high throughput proteomics applications with more than 18 years of experience in proteomics and mass spectrometry. Nagarjuna obtained his PhD from the Matthias Mann lab focusing on sample preparation and MS data acquisition strategies for clinical applications. After a postdoc he directed the mass spectrometry core facility at the Max-Planck-Institute of Biochemistry working on a wide range of protein and peptide mass spectrometry projects such as bottom-up proteomics, structural mass spectrometry including HDX, native and crosslinking MS, intact protein and small molecule analysis.
</blockquote>
<blockquote>
Presenter: Dr. Alexander Boychenko (Head of R&amp;D Laboratory Precision Medicine Markers, Bayer)
</blockquote>
<blockquote>
Alexander Boychenko is leading Omics Research within the Translational Sciences team of the Pharmaceuticals division at Bayer Group. He is focused on implementing innovative analytical technologies and developing novel methodologies for proteomics, metabolomics, and ligand-binding assays (LBA) to comprehensively characterize human and animal model phenotypes, enabling disease understanding and novel biomarker discovery. He holds a Ph.D. in Analytical Chemistry from Kharkiv National University, Ukraine. During his post-doctoral work at the University of Groningen, The Netherlands, he combined LC-MS and immunoassays to discover and validate protein biomarkers in biofluids for cancer screening. Before joining Research and Early Development at Bayer AG, he developed and introduced new liquid chromatography-mass spectrometry products at Thermo Fisher Scientific. Alexander is a subject matter expert in LC-MS, biological data interpretation, and precision medicine. He utilizes his passion for applying technical expertise to develop new medicines.
</blockquote>
<blockquote>
Presenter: Dr. Alec Valenta (Product Marketing Manager, Thermo Fisher Scientific)
</blockquote>
<blockquote>
Alec is the product marketing manager for the Vanquish Neo UHPLC system and low-flow LC columns. Prior to joining Thermo Fisher Scientific he earned his PhD in analytical chemistry from the University of Michigan where he helped advance microdialysis sampling of neurochemicals and developed LC-MS methods to quantify small molecule neurotransmitters, neuropeptides, and metabolites in a variety of complex biological samples.
</blockquote>

Thermo Scientific: A Tandem LC Workflow for Maximizing Mass Spectrometer Utilization in Proteomics

A Tandem LC Workflow for Maximizing Mass Spectrometer Utilization in Proteomics

How experts from Evotec and Bayer implemented the tandem direct injection workflow for their proteomics work.

A Tandem LC Workflow for Maximizing Mass Spectrometer

Join us for an exclusive two-day event where Agilent will showcase cutting-edge biopharma solutions.
The first day of the event we will explore Agilent’s comprehensive portfolio for the spectrum of applications from drug discovery to quality control. Learn more about our cell analysis and genomics expertise and the tools we provide to drive IVT mRNA development, protein therapeutics and cell and gene therapies
The second day will focus on advanced analytical solutions, including HRMS for tRNA sequencing and LC/MS for DNA/RNA analysis. Learn how to scale up oligonucleotide purification with Agilent biocolumns, which enhance the efficiency and accuracy of your processes.
By attending this event you will:
<ul>
<li>Gain insights from Agilent to optimize biotherapeutic workflows, including rigorous quality testing in cGMP environments and handling nucleic acid, vaccines, mAB and protein samples.
</li>
<li>Understand how metabolic analyses can impact CAR cell function and behavior, using cytolytic cell killing assays on the xCELLigence system to develop cell therapy processes and confirm product potency.
</li>
<li>Learn about new techniques in high-resolution LC/MS for analyzing tRNA modifications.
</li>
<li>Discover software tools available for high-resolution MS systems in both research and QA/QC labs.
</li>
<li>Compare analytical and semipreparative LC purification methods for synthetic oligonucleotides, gaining competitive insights into purification strategies.
</li>
</ul>
<h5>Talk 1: Agilent Tools and Technologies to Drive Advancements in Biopharmaceutical Drug Development</h5>
<ul>
<li>Presented by Dr. Hervé Chaulet, Molecular and Biological Research Market Specialist, Agilent Technologies</li>
</ul>
Discovering, developing, and manufacturing biopharmaceuticals requires you to stay abreast of advances in knowledge and improvements in technology while constantly navigating a maze of business and scientific challenges. Agilent can be a trusted partner providing expertise and end-to-end workflows including systems, software, consumables, and services for the spectrum of applications from drug discovery to quality control. Learn more about our cell analysis and genomics expertise and the tools we provide to drive IVT mRNA development, protein therapeutics, and cell and gene therapies.
<h5>Talk 2: Quality Control In IVT mRNA Therapeutics and Vaccine Development Workflow Using The Agilent Fragment Analyzer System</h5>
<ul>
<li>Presented by Dr. Leslie Friedmann, Product Manager, Agilent Technologies</li>
</ul>
Reliable and robust analysis is essential throughout in vitro transcription (IVT) mRNA workflows, providing important quality information to help minimize risk and aid in the production of a consistent product. The Agilent Fragment Analyzer systems can be used for several QC steps at different checkpoints in mRNA vaccine development, providing accurate and precise sizing and integrity analysis. These QC steps are to determine the quality and size of the linearized plasmid, the size and purity of the IVT mRNA, length of the poly(A) tail, and purity of the final mRNA vaccine product.
<h5>Talk 3: Analysis of NIST mAb Reference Material by Parallel SDS-Capillary Electrophoresis</h5>
<ul>
<li>Presented by Dr. Kyle Luttgeharm, Product Manager, Agilent Technologies</li>
</ul>
Monoclonal antibody drug products are complex biomolecules that must be tested for critical quality attributes (CQAs) such as monomeric purity and percent glycosylation. Capillary gel electrophoresis methods have been adopted as the standard method for size heterogeneity characterization, however legacy capillary electrophoresis (CE) methods involve complicated workflows or are cost prohibitive. To address these problems with legacy methods, Agilent has developed a 12-channel, parallel capillary electrophoresis-SDS (CE-SDS) instrument and reagents. The system uses a high-resolution sieving gel, allowing for resolution of mAb species including the non-glycosylated heavy chain and light chain. To demonstrate the capabilities of the ProteoAnalyzer, the NIST mAb was characterized under both reduced and non-reduced conditions and compared to the NIST data sheet.
<h5>Talk 4: Advanced Analytics for Cell Therapy Research, Process Development, and Manufacturing</h5>
<ul>
<li>Presented by Dr. Kelly Kroeger, Science &amp; Technology Advisor, Agilent Technologies</li>
</ul>
With immunology and immune-based therapies rising as a pillar of science and therapeutics, we are seeing a foundational shift from targeting specific proteins and pathways to actually targeting the immune cellular network that resolves and prevents disease. Therefore there is a critical need for cell analysis tools to facilitate understanding of the dynamic nature of the interaction of these cellular networks whether it is in the context of immune cells or immune cells with cancer cells.
To address these new challenges, we at Agilent Technologies have developed a portfolio of cell analysis solutions that provide researchers with more relevant tools to measure living cells, dynamically track them, and model their microenvironments. These next-generation therapies require methods and technologies to enable assessment of real-time cell function, phenotype, and fate. Used together, the Agilent tool bench provides the capability to measure and develop immune cell function more effectively, thus enabling translational researchers and developers to achieve the necessary level of potential therapeutic potency and safety.

Technology Networks: Biopharma Innovations Summit

Biopharma Innovations Summit Day 1

Learn more about our cell analysis and genomics expertise and the tools we provide to drive IVT mRNA development.

Join us for an exclusive two-day event where Agilent will showcase cutting-edge biopharma solutions.
The first day of the event we will explore Agilent’s comprehensive portfolio for the spectrum of applications from drug discovery to quality control. Learn more about our cell analysis and genomics expertise and the tools we provide to drive IVT mRNA development, protein therapeutics and cell and gene therapies
The second day will focus on advanced analytical solutions, including HRMS for tRNA sequencing and LC/MS for DNA/RNA analysis. Learn how to scale up oligonucleotide purification with Agilent biocolumns, which enhance the efficiency and accuracy of your processes.
By attending this event you will:
<ul>
<li>Gain insights from Agilent to optimize biotherapeutic workflows, including rigorous quality testing in cGMP environments and handling nucleic acid, vaccines, mAB and protein samples.
</li>
<li>Understand how metabolic analyses can impact CAR cell function and behavior, using cytolytic cell killing assays on the xCELLigence system to develop cell therapy processes and confirm product potency.
</li>
<li>Learn about new techniques in high-resolution LC/MS for analyzing tRNA modifications.
</li>
<li>Discover software tools available for high-resolution MS systems in both research and QA/QC labs.
</li>
<li>Compare analytical and semipreparative LC purification methods for synthetic oligonucleotides, gaining competitive insights into purification strategies.
</li>
</ul>
<h5>Talk 1: Advanced Analytical Solutions for Nucleic Acid Analysis and Purification</h5>
<ul>
<li>Presented by Dr. Charlotte Lekieffre, Biopharma Application Specialist, Agilent Technologies</li>
</ul>
The emphasis during the second day of the Summit will be on advanced analytical solutions, such as HRMS for tRNA sequencing and LC/MS for DNA/RNA analysis. Additionally, you’ll discover techniques to enhance the efficiency and accuracy of your processes by scaling up oligonucleotide purification using Agilent biocolumns. 
<h5>Talk 2: Extracted Yeast tRNA Sequencing by LC-MS/MS</h5>
<ul>
<li>Presented by Aurore Attina, Engineer of Mass Spectrometry, University of Montpellier</li>
</ul>
RNA modifications are essential for RNA stability, maturation, and functionality; directly influencing protein translation and gene regulation. They play a central role in various biological processes and are associated with many diseases, including cancers and neurological disorders. tRNA (transfer RNA), which plays a key role in protein synthesis, is the most modified molecule in the organism known to date. tRNA modifications are essential to ensure their correct function in protein translation, maintain the accuracy and fidelity of the genetic code, and enable flexible adaptation to changing cellular conditions and are therefore a crucial attribute to monitor. To monitor and map these modifications of tRNA, we have developed a LC-HRMS analytical workflow, first using synthetic oligonucleotide for the method optimization. In this webinar, we will first go through the various steps involved in LC-MS/MS method optimization using synthetic oligonucleotides. In a second part, we will present the protocol development of an enzymatic digestion applied to tRNA extracted from yeast. This digestion generates oligonucleotide fragments that can be analyzed by LC-MS/MS for sequence confirmation.
<h5>Talk 3: Discover Agilent’s Software Tools to Confirm Oligonucleotide Sequence Integrity</h5>
<ul>
<li>Presented by Dr. Holger Stalz, LC/MS Product Specialist Austria &amp; Switzerland, Agilent Technologies</li>
</ul>
Mass spectrometry (MS) is increasingly important for the development of therapeutic modalities such as oligonucleotides. A common analytical method for large molecules is intact mass by LC/MS. This can be used for the characterization and identification of a product or process-related impurities, or simply as a confirmation of molecular weight. The newly introduced Agilent OpenLab CDS 2.8 SW version comes with a set of features to enable the automatization of biopharma workflows. If you want to know how LC/MSD Spectral Deconvolution of your biopharma samples can be automated, we will provide answers during our presentation. Even more details on Oligonucleotide sequence confirmation and impurities characterization can be acquired using the power of a high-resolution accurate mass system (HRAM) on the Agilent 6545XT AdvanceBio LC/Q-TOF. Analyzing the sample data with the software workflows in Agilent BioConfirm version 12 will support the user to get the trusted answers to their most relevant questions.
<h5>Talk 4 Maximize Your Resources and Simplify Scale-up with AdvanceBio Oligonucleotide Columns</h5>
<ul>
<li>Presented by Dr. Andrea Tripodi, Application Development Engineer, Agilent Technologies</li>
</ul>
Several classes of nucleic acids, such as antisense oligonucleotides, small interfering RNAs (siRNAs), and aptamers are being investigated for potential therapeutic applications. Synthetic oligonucleotides inevitably contain many impurities due to limitations in the efficiency of each chemical reaction used during manufacture. They include deletion sequences (missing one or more nucleotides) and reaction by-products often arising during the final deprotection or cleavage steps. Ion pair reversed-phase (IP-RP) chromatography stands out as the prevalent method for analyzing and purifying oligonucleotides. For increased resolution and separation of your full-length synthetic oligonucleotide from closely related impurities, AdvanceBio Oligonucleotide is the ideal choice. The latest developments include semi-preparative, and lab-scale preparative columns packed with superficially porous particles that provide excellent performance and resolution without compromising column loading. A fast and easy scale-up method from analytical to semi-preparative scale was successfully achieved using a 10 mm ID column enabling higher sample loading using the same analytical LC instrument.

Biopharma Innovations Summit Day 2

The allowable adjustments to compendial methods published in USP General Chapter 621 and Ph. Eur. 2.2.46 provide scope for analysts to migrate methods to smaller column dimensions, providing advantages in terms of time and cost savings.This webinar will provide insight into the considerations necessary when applying allowable adjustments to gradient monographs.<h4>Key Learning Points:</h4><ul><li>Learn about Allowable adjustments possible when working with gradient monograph methods</li><li>Understand system considerations in terms of dwell volume</li><li>Dig into calculations to perform in order to scale gradient conditions correctly</li></ul><h4>Who Should Attend:</h4><ul><li>Any analysts working with pharmacopeia methods or chromatographers who work with gradient methods&nbsp;</li></ul><blockquote>Presenter: James Turner (Global Market Manager, Phenomenex)With more than 25 years of experience at Phenomenex, James has been responsible for providing specialist technical support to customers across Europe with method development assistance, troubleshooting advice and chromatographic solutions to various customer problems. James has also been involved with the technical training of many Phenomenex technical consultants, across the multiple techniques we serve.</blockquote>

Phenomenex: Working with Allowed Adjustments Pharmacopeia HPLC Methods – Gradient Considerations

Working with Allowed Adjustments Pharmacopeia HPLC Methods – Gradient Considerations

Insight into the considerations necessary when applying allowable adjustments to gradient monographs.

Working with Allowed Adjustments Pharmacopeia HPLC

This seminar will guide you through troubleshooting HPLC systems and chromatographic issues using a structured workflow.We will share a novel approach to emphasize the importance of system monitoring, as troubleshooting without monitoring is considerably more challenging. After introducing some key concepts and a troubleshooting workflow, we'll explore practical examples by applying the workflow to failed chromatograms to identify the cause of failure and then use a test cycle to confirm the fix.Who should attend: Analysts working in regulated environments (eg. GLP, GMP) or in non-regulated environments (eg. R&amp;D) who want to troubleshoot their HPLC systems and chromatographic problems effectively.<h4>Key Learnings:</h4>1. The importance of routine system monitoring2. Using qualification checks to diagnose a failure3. Understanding Failure Indicators (HOW the chromatogram failed) vs. Failure Causes (WHY the chromatogram failed)4. Using troubleshooting workflows to quickly identify the failure cause<blockquote>Presenter: Maureen DeLoffi (Senior Product Manager, Waters COrporation)Maureen DeLoffi is a Senior Product Manager at Waters Corporation, where she manages the small molecule portfolio of Analytical HPLC columns. Prior to her Product Manager role, she spent over 12 years as a scientist in the Column Technology Development Lab at Waters. She holds a bachelor’s degree in Mechanical Engineering from the University of New Hampshire.</blockquote>

Waters Corporation: HPLC Troubleshooting: A System Monitoring Approach

HPLC Troubleshooting: A System Monitoring Approach

Troubleshooting HPLC systems and chromatographic issues using a structured workflow.

<h4>The Waters 2024 Virtual Summer School - An Educational Journey to Master Food &amp; Environmental Analysis</h4>Unlock the full potential of LC-MS techniques with our immersive and educational sessions at the Waters Virtual F&amp;E Late Summer School 2024. From September 24th to 26th, engage with leading experts and discover cutting-edge methods for environmental and food analysis.<h5>Why attend?</h5><ul><li>Comprehensive Learning: Dive deep into advanced LC-MS techniques and gain practical knowledge to enhance your laboratory's analytical capabilities.</li><li>Expert Insights: Learn from industry leaders and gain firsthand experience through detailed modules on chromatography, mass spectrometry, and sample preparation.</li><li>Regulatory Compliance: Stay ahead with the latest insights on EU regulations for PFAS analysis in food and water, ensuring your lab meets stringent standards.</li></ul><h3>Episode #1: Chromatography - UPLC | F&amp;E Summer School - Day 1 - Module 1</h3>This section will provide an overview of the Waters reference material available to customer to help plan the best columns and chromatographic conditions for their LC-MS methods, using common environmental contaminants as an example. We highlight how to create LC-MS methods using the Acquisition Method Editor (AME) application within waters_connect™. Finally, this section will cover some of the most troubleshooting issues: contaminated blank peaks, poor peak shape, etc, and how to address them.<h5>What you'll learn:</h5><ul><li>Important factors for developing a UPLC method - considering analyte solubility, pKa and partitioning coefficient (Kow)</li><li>Selecting the most appropriate UPLC column for your analytes</li><li>Setting up LC-MS methods in the waters_connectTM console</li><li>Troubleshooting common contamination issues</li></ul><blockquote>Presenter: Nicole Baumgarten (Sr Sales Applications Chemist, Waters Corporation)Nicole is part of the Customer Success team at Waters with a focus on LC-MS/MS application and sales support. She works in this role for more than 9 years and gained experience in previous roles as analyst for biopharmaceuticals in process controls at Boehringer Ingelheim and research Assistent at Zentrum für Humangenetik und Laboratoriumsmedizin in Munich after finishing a Master of Chemical engineering at Hochschule Fresenius, Idstein.Presenter: Caroline Davis (Sr Sales Applications Chemist, Waters Corporation)</blockquote>

Waters Corporation: The Waters 2024 Virtual Summer School

Chromatography - UPLC

An overview of the Waters reference material available to customer to help plan the best columns and chromatographic conditions for their LC-MS methods.

Chromatography - UPLC 

<h4>The Waters 2024 Virtual Summer School - An Educational Journey to Master Food &amp; Environmental Analysis</h4>Unlock the full potential of LC-MS techniques with our immersive and educational sessions at the Waters Virtual F&amp;E Late Summer School 2024. From September 24th to 26th, engage with leading experts and discover cutting-edge methods for environmental and food analysis.<h5>Why attend?</h5><ul><li>Comprehensive Learning: Dive deep into advanced LC-MS techniques and gain practical knowledge to enhance your laboratory's analytical capabilities.</li><li>Expert Insights: Learn from industry leaders and gain firsthand experience through detailed modules on chromatography, mass spectrometry, and sample preparation.</li><li>Regulatory Compliance: Stay ahead with the latest insights on EU regulations for PFAS analysis in food and water, ensuring your lab meets stringent standards.</li></ul><h3>Episode #9: PFAS in Food | F&amp;E Summer School - Day 3 - Module 1</h3>The European Commision published for the first time maximum levels for the so-called “EU 4” PFAS (PFHxS, PFOS, PFOA and PFNA) in eggs, meat and fish with Regulation EU 2023/915. This was an expected result of EFSA’s letter of concern on those 4 PFAS and labs reacted accordingly. A more challenging task came with the EURL PFAS Guidance Document and a bit later with the Recommendation EU 2022/1431. The target LOQs for the EU 4 PFAS were set at 0.001 µg/kg in fruits, vegetables and babyfood. We will discuss the successful method implementation from sample preparation to final report and hear real-life experiences from our guest speaker Victoria Erdely (Eurofins GfA) and Katharina Rund (EURL PFAS).<h5>What you'll learn:</h5><ul><li>How to reach lowest levels of PFAS in food and work according to Recommendation EU 2022/1431 using Xevo TQ Absolute in combination with UniSpray ion source</li><li>How LC method development on Premier LC gives you the widest PFAS panel and separates interferences.</li><li>Tips &amp; tricks from the demo lab to avoid PFAS contamination, implement new analytes, speed up data processing, and keep best performance of your system</li><li>About a special PFAS training to help you implement the method in the lab.</li></ul><blockquote>Presenter:&nbsp;Dr. Sara Stead (Consulting Scientist, Food and Environmental, Scientific Operations, Waters Corporation)In her current position, Sara is a Principal Sales Application Chemist specializing in food and environmental LC-MS/MS based applications within the Waters UK and Ireland demo laboratory. Sara has worked in F&amp;E analysis with various research interests including the development of both multi-residue HRMS screening and targeted LC/GC MS based methods for the past 25 years in both the government and private sectors. ​Prior to joining Waters Sara was employed as a Lead Scientist at the Food and Environment Research Agency (FERA, Defra, UK) for 14 years. Sara has participated in EU Food and Veterinary Office (FVO) audit inspections, was an expert on behalf of the International Atomic Energy Agency (IAEA) and a member of the EuroResidue conference scientific committee.Presenter:&nbsp;Dr. Stuart Adams (Principal Scientist, Market Development, Food and Environmental Applications, Europe, Waters Corporation)Stuart has been developing methods for the determination of contaminants in food and the environment for over 17 years and has been with Waters Corporation since 2018. Stuart's previous role was as a senior analytical chemist at Fera (the UK’s National Reference Laboratory) and moved to Waters to focus on application development in the European region. He now serves as the attached scientist to the European Market Development team responsible for the food and environmental application areas. In his role, he works with customers to understand their analytical challenges and helps address them with Waters technologies.Presenter:&nbsp;Victoria Erdely (Head of Department - Method and Instrument Support, Eurofins GfA)Presenter:&nbsp;Dr. Katharina Rund (Food Chemist, EU Reference Laboratory for halogenated POPs in Feed and Food)</blockquote>

PFAS in Food

We will discuss the successful method implementation from sample preparation to final report and hear real-life experiences.

<h4>Overview</h4>We invite you to our 2nd Annual Virtual Biosymposium. This year, we will explore novel analytical characterization and quantitation of emerging modalities, such as DNA and mRNA, along with key method development considerations with global thought leaders.We look forward to seeing you! Key Event Objectives:<ul><li>Learn about novel approaches to characterizing established and modern biotherapeutic modalities</li><li>Understand key considerations when developing characterizing and quantitating methods for biomolecules</li><li>Take a deep dive into the values of fit-for-purpose methods to make critical drug decisions</li></ul>AGENDA7:30am AM (PT) - Welcoming Introductions<ul><li>Tran N. Pham, Global Biopharma Market Development Manager at Phenomenex</li></ul>7:35 AM (PT) - "Solutions &amp; Characterization Strategies for IVT mRNA Therapy Development"<ul><li>Charles Bai, Lead Application Scientist, VectorBuilder, Chicago, USA</li></ul>8:05 AM (PT) - &nbsp;"Utilizing Size Exclusion Chromatography for the Quality Control Analysis of Gene Therapeutics”<ul><li>Rebecca Hirschberger, QC Manager Bioanalytical Implementation, and Dr. Christopher Gawlig, QC Manager Research and development, Biospring, Germany</li></ul>8:35 AM (PT) "Impurity Profiling Optimization of GalNAc-conjugated Oligonucleotides by LC-MS-UV"<ul><li>Roxana Eggleston-Rangel, Senior Applications Scientist, Phenomenex, California, USA</li></ul>9:05 AM (PT) – Round Table Q&amp;A<ul><li>Tran N. Pham, Global Biopharma Market Development Manager at Phenomenex</li></ul>9:25 AM (PT) – Closing Remarks<blockquote>Presenter: Charles Bai (Lead Application Scientist)Charles has received his PhD in Microbiology at Purdue University. As a Lead Application Scientist at VectorBuilder, his main responsibilities are to provide technical consultation for clients regarding gene delivery using viral and non-viral vectors. Regarding the application of in vitro transcribed (IVT) RNA, Charles has been helping researchers with the design, production and encapsulation of IVT mRNA, circRNA or saRNA for therapy and vaccine development.Presenter: Rebecca Hirschberger (Quality Control Bioanalytical Method Development)Rebecca has been in the chromatography industry for over 2 years and has practical experience in the quality control of gene therapeutics. She has earnt a Masters in pharmaceutical science from Ludwig-Maximilians University, Munich, focused on instrumental analytics. Since Dezember 2022 she is a licensed Pharmacist in Germany. Rebecca Hirschberger joined BioSpring in August of 2021 and she serves as QC Manager Bioanalytical Implementation. Her area of responsibility includes: Various analyses of oligonucleotides, including (tandem) mass spectrometry via qToF, biochemical techniques, i.e. ELISA, enzymatic transformation of oligonucleotides for analytical and quality control purposes and the Separation of oligonucleotides by chromatographic methods.Presenter: Roxana Eggleston-Rangel (Senior Applications Scientist, Phenomenex)Roxana joined Phenomenex in 2018 as an Applications Scientist and is currently working with the applications team to produce analytical solutions for scientist in the biopharma industry. Roxana’s current work focuses on characterization of mRNA, sgRNA and siRNA. Prior to Phenomenex, Roxana worked for Caltech and the University of Southern California developing LM-CS workflows for the proteomics community. Roxana Eggleston-Rangel received her bachelor’s and master’s degree in Chemistry and Biochemistry from California State University, Los Angeles.</blockquote>

Phenomenex: 2nd Annual Virtual Biosymposium

2nd Annual Virtual Biosymposium

Explore novel analytical characterization and quantitation of emerging modalities, such as DNA and mRNA

LCMS webináře se zaměřením na HPLC - strana 20

PFAS in Food

Biopharma Innovations Summit Day 2

HPLC Troubleshooting: A System Monitoring Approach

Biopharma Innovations Summit Day 1

Chromatography - UPLC

Lipid nanoparticles

2nd Annual Virtual Biosymposium

Working with Allowed Adjustments Pharmacopeia HPLC Methods – Gradient Considerations

A Tandem LC Workflow for Maximizing Mass Spectrometer Utilization in Proteomics

Quality Control of Purified Proteins to Improve Research Data Reproducibility: Improving the Time-Efficiency and Quality of Your Results

Mohlo by Vás zajímat

LabRulez na veletrhu analytica 2026

Lukáš Kučera pro National Geographic: Tradice versus nová vlna

Waters VIZE 2025: Stanovení nitrosaminů v uzeninách

LCMS webináře se zaměřením na HPLC - strana 20

PFAS in Food

Biopharma Innovations Summit Day 2

HPLC Troubleshooting: A System Monitoring Approach

Biopharma Innovations Summit Day 1

Chromatography - UPLC

Lipid nanoparticles

2nd Annual Virtual Biosymposium

Working with Allowed Adjustments Pharmacopeia HPLC Methods – Gradient Considerations

A Tandem LC Workflow for Maximizing Mass Spectrometer Utilization in Proteomics

Quality Control of Purified Proteins to Improve Research Data Reproducibility: Improving the Time-Efficiency and Quality of Your Results​

Mohlo by Vás zajímat

LabRulez na veletrhu analytica 2026

Lukáš Kučera pro National Geographic: Tradice versus nová vlna

Waters VIZE 2025: Stanovení nitrosaminů v uzeninách

Quality Control of Purified Proteins to Improve Research Data Reproducibility: Improving the Time-Efficiency and Quality of Your Results